Elevance Health Pays $342M Amid Medicare Billing Probe

Elevance Health Settles $342M Medicare Billing Dispute

Elevance Health, one of the nation's largest Medicare Advantage insurers, has paid $342 million to the Centers for Medicare & Medicaid Services (CMS) in connection with an ongoing billing investigation, according to KFF Health News. The payment came as CMS reportedly threatened to block new enrollments in Elevance's Medicare Advantage plans — a significant enforcement action that signals heightened federal scrutiny of how insurers submit billing data under the program.

For the millions of Americans enrolled in Elevance-affiliated Medicare Advantage plans — including plans marketed under the Anthem brand and others — this development raises legitimate questions about plan stability, regulatory oversight, and what to expect heading into the next enrollment season.

Background: How Medicare Advantage Billing Works

Medicare Advantage insurers receive fixed monthly payments from the federal government for each enrollee, with those payments adjusted upward based on how sick or medically complex a member's conditions are. This system, known as risk adjustment, is intended to ensure insurers are compensated fairly for covering patients with more serious health needs.

Federal regulators and auditors have raised concerns for years that some Medicare Advantage insurers may submit diagnosis codes in ways that make members appear more medically complex than documented clinical records support — a practice that, if confirmed, would result in the government overpaying those insurers. CMS has been conducting payment audits across the Medicare Advantage industry for years and has signaled stronger enforcement activity in 2025 and 2026.

Elevance Health has not publicly admitted wrongdoing in connection with this payment. The company, formerly known as Anthem before rebranding, operates some of the largest Medicare Advantage networks in the country. The $342 million payment is a substantial sum even for a company of Elevance's scale, and the threatened enrollment restriction — if imposed — could meaningfully affect the company's Medicare business going forward.

What the Enrollment Threat Means in Practice

Among the most notable elements of this report is CMS's apparent threat to bar Elevance from accepting new Medicare Advantage enrollees. While this type of enforcement action is relatively rare, it is not unprecedented. CMS has the legal authority to sanction Medicare Advantage organizations that fail to meet compliance standards, with restrictions on marketing or enrollment among its available tools.

For people already enrolled in an Elevance Medicare Advantage plan, a marketing or enrollment suspension would not necessarily disrupt existing coverage. Individuals enrolled in a plan generally retain their benefits even when an insurer faces regulatory action. However, potential restrictions could affect choices during the Annual Enrollment Period (AEP), which runs from October 15 to December 7, if Elevance plans are temporarily unavailable to new applicants in certain markets.

The threat of enrollment restrictions appears to have preceded the payment, suggesting the $342 million figure may reflect, at least in part, a negotiated resolution. The full scope of the billing dispute — including which plan years or specific diagnosis categories are under review — has not been comprehensively detailed in publicly available reporting as of late June 2026.

A Broader Signal for Medicare Advantage Oversight

The Elevance payment is part of a broader trend. CMS and the Department of Justice have intensified scrutiny of Medicare Advantage billing practices across the industry over the past several years. Multiple large insurers have faced audits, payment clawbacks, or legal challenges related to risk adjustment data. Government estimates have long suggested that potential overpayments across the Medicare Advantage program run into the billions of dollars annually, and federal enforcement efforts have continued regardless of which administration is in power.

For consumers, this regulatory environment has a few practical implications worth understanding:

• Plan stability is worth monitoring. A plan under active government scrutiny may face operational pressure. It is reasonable to watch for any announcements from Elevance or CMS about service area changes, network adjustments, or enrollment restrictions as fall 2026 approaches.
• Medicare Advantage plans can exit markets. While no plan exits have been announced in connection with this situation, historical precedent shows that regulatory or financial pressure can lead plans to withdraw from certain counties or states. Knowing your fallback options — including Original Medicare paired with a Medigap supplement plan and a standalone Part D prescription drug plan — is prudent planning.
• Audit recoveries support the Medicare trust fund. When CMS recovers funds tied to potential overpayments, those recoveries are intended to protect the program's long-term financial footing. Reduced overpayments, in theory, contribute to Medicare's sustainability over time.

Plan performance varies significantly by region. An Elevance-affiliated plan in one state may have very different network quality, cost-sharing, and Star Ratings than a plan in another market. CMS's annual Star Ratings system and the Medicare Plan Finder tool at medicare.gov remain the best starting points for comparing what is available in your specific area.

What to Watch in the Months Ahead

This story continues to develop. Key developments worth tracking before and during the fall 2026 enrollment season include:

• Whether CMS formally implements any enrollment restrictions on Elevance plans, and which markets would be affected
• Additional public disclosures about the scope of the billing review and which plan years were examined
• Elevance's formal response or any statements in its investor filings about the settlement and its implications
• Whether other large Medicare Advantage insurers face comparable actions as CMS's audit program continues

For seniors and their families making Medicare coverage decisions in 2026, the most important near-term step is straightforward: begin reviewing your plan options before the Annual Enrollment Period opens in October rather than waiting until the final days. If you are currently in an Elevance Medicare Advantage plan and are uncertain about what this situation means for your coverage, speaking with a SHIP counselor — a free, unbiased service available in every state — is a smart first move. You can also work with a licensed, independent Medicare insurance agent to compare alternatives. Avoid making changes to your coverage outside of designated enrollment windows without fully understanding how a switch would affect your benefits and costs.